Adults 8 to 12, any sex, with Dietary Habits or Health Behavior. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Estimated Change in Child Fruit & Vegetable Self-efficacyPrimary· Beginning to end of school year 2019-20 ( Baseline and ~ 8 months)
Self-efficacy for eating F\&V score is average of responses to five 4-point Likert scale questions. Higher score is higher self-efficacy. Score range is 1 to 4.
Change in self-efficacy is based on a model that uses all available data (from baseline and 8-month follow-up). The unit of analysis is participant-timepoint. The analysis accounts for nesting within schools.
Using a repeated measures linear mixed model analysis, the results are estimated change in self-efficacy score from baseline to 8-month follow-up, contrasting intervention group to comparison group.
From the model, the estimate
Group
Value
95% CI
Intervention Group
0.47
± 0.08
Comparison Group
0.24
± 0.05
Estimated Change in AHEI Healthy Foods ScorePrimary· Beginning to end of school year 2019-20 ( Baseline and ~ 8 months).
The Healthy Foods Score is a subscale from the modified Alternative Healthy Eating Index (AHEI). Data were derived from a picture sort frequency tool estimating consumption frequencies of ten major food groups of the Navajo diet. Scoring used the published AHEI-2010.
The subscale is the sum of scores for fruits (fresh \& dried), vegetables (not salad), whole grains, beans, nuts, only. Values range from 0 to 36. Higher values represent a better outcome.
Change in Score is based on a model that uses all available data (from baseline and 8-month follow-up).
The model is from a repeated measure
Group
Value
95% CI
Intervention Group
1.98
± 0.85
Comparison Group
0.58
± 0.61
Estimated Ratio of Full Self-efficacy to Grow F&V at SchoolPrimary· Beginning to end of school year 2019-20 ( Baseline and ~ 8 months)
Measure derived from Percent of participants at each time point reporting "I know I can".
Using generalized mixed models, specifying a binomial distribution, accounting for nesting within schools, the Odds ratio of 8-month follow-up to baseline percent reporting "I know I can" was estimated for both intervention and comparison groups. The overall range in these odds ratios was 0.95 to 3.63 .
The contrast of intervention group to comparison group was also an odds ratio.
Group
Value
95% CI
Intervention Group
1.92
1.02 – 3.63
Comparison Group
1.48
0.95 – 2.31
Sponsor's own description
In this study, one year changes in healthy eating and gardening behaviors associated with the intervention were estimated using a group randomized controlled trial design, with the comparison arm receiving a delayed intervention in the following school year.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07385820 — A Comparative Intervention Study on Strategies for Fruit Distribution and Awareness Campaigns in Schools
· NA
· recruiting
NCT07027865 — Sip and Snack Better (SSB) Study: Improving Added Sugar in Adolescents
· NA
· active not recruiting
NCT07411677 — My Life - I Decide: A Health Promoting School Intervention
· NA
· active not recruiting
NCT05862818 — Can Food Timing Reduce Your Diabetes Risk?
· NA
· recruiting
NCT06912425 — Effects of an Exercise and Diet Program on Biochemistry and Body Composition in Patients With CKD in G1 and G2 Stages
· NA
· recruiting
Other Fred Hutchinson Cancer Center trials
Trials by the same sponsor.
NCT07390968 — Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Pati
· Phase 2
· not yet recruiting
NCT07493252 — A Behavioral Application for Improving Smoking Cessation Among Smokers
· NA
· not yet recruiting
NCT07490860 — A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to
· NA
· not yet recruiting
NCT07194980 — Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small L
· Phase 2
· not yet recruiting
NCT07176000 — Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington S
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fred Hutchinson Cancer Center
Last refreshed: 23 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03778021.